Cargando…
Robuste T-Zell-Immunantwort nach COVID-19-mRNA-Impfung trotz Anti-CD20-Therapie in der multiplen Sklerose
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686102/ http://dx.doi.org/10.1007/s42451-021-00403-w |
| _version_ | 1784617950489083904 |
|---|---|
| author | Wirth, T. |
| author_facet | Wirth, T. |
| author_sort | Wirth, T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8686102 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Medizin |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86861022021-12-20 Robuste T-Zell-Immunantwort nach COVID-19-mRNA-Impfung trotz Anti-CD20-Therapie in der multiplen Sklerose Wirth, T. DGNeurologie Scientific News Springer Medizin 2021-12-20 2022 /pmc/articles/PMC8686102/ http://dx.doi.org/10.1007/s42451-021-00403-w Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Scientific News Wirth, T. Robuste T-Zell-Immunantwort nach COVID-19-mRNA-Impfung trotz Anti-CD20-Therapie in der multiplen Sklerose |
| title | Robuste T-Zell-Immunantwort nach COVID-19-mRNA-Impfung trotz Anti-CD20-Therapie in der multiplen Sklerose |
| title_full | Robuste T-Zell-Immunantwort nach COVID-19-mRNA-Impfung trotz Anti-CD20-Therapie in der multiplen Sklerose |
| title_fullStr | Robuste T-Zell-Immunantwort nach COVID-19-mRNA-Impfung trotz Anti-CD20-Therapie in der multiplen Sklerose |
| title_full_unstemmed | Robuste T-Zell-Immunantwort nach COVID-19-mRNA-Impfung trotz Anti-CD20-Therapie in der multiplen Sklerose |
| title_short | Robuste T-Zell-Immunantwort nach COVID-19-mRNA-Impfung trotz Anti-CD20-Therapie in der multiplen Sklerose |
| title_sort | robuste t-zell-immunantwort nach covid-19-mrna-impfung trotz anti-cd20-therapie in der multiplen sklerose |
| topic | Scientific News |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686102/ http://dx.doi.org/10.1007/s42451-021-00403-w |
| work_keys_str_mv | AT wirtht robustetzellimmunantwortnachcovid19mrnaimpfungtrotzanticd20therapieindermultiplensklerose |